综述 |
|
|
|
|
分子伴侣HSP40/DNAJ蛋白家族及其在神经退行性疾病中的作用 |
何颖慧,王志萍 |
浙江大学医学院脑科学与脑医学学院 浙江大学医学院神经科学中心 国家卫生 健康委员会医学神经生物学重点实验室 中国医学科学院医学神经生物学重点 实验室,浙江 杭州 310058 |
|
The roles of HSP40/DNAJ protein family in neurodegenerative diseases |
HE Yinghui,WANG Zhiping |
School of Brain Science and Brain Medicine, Center for Neuroscience, Zhejiang University School of Medicine, NHC Key Laboratory of Medical Neurobiology, CAMS Key Laboratory of Medical Neurobiology, Hangzhou 310058, China |
33 |
GREAVESJ, CHAMBERLAINL H. Dual role of the cysteine-string domain in membrane binding and palmitoylation-dependent sorting of the molecular chaperone cysteine-string protein[J]Mol Biol Cell, 2006, 17( 11): 4748-4759.
doi: 10.1091/mbc.e06-03-0183
|
34 |
DIEZ-ARDANUYC, GREAVESJ, MUNROK R, et al.A cluster of palmitoylated cysteines are essential for aggregation of cysteine-string protein mutants that cause neuronal ceroid lipofuscinosis[J]Sci Rep, 2017, 7( 1): 10.
doi: 10.1038/s41598-017-00036-8
|
35 |
HUANGQ, ZHANGY F, LIL J, et al.Adult-onset neuronal ceroid lipofuscinosis with a novel DNAJC5 mutation exhibits aberrant protein palmitoylation[J]Front Aging Neurosci, 2022, 829573.
doi: 10.3389/fnagi.2022.829573
|
36 |
FONTAINES N, ZHENGD, SABBAGHJ J, et al.DNAJ/HSC70 chaperone complexes control the extracellular release of neurodegenerative‐associated proteins[J]EMBO J, 2016, 35( 14): 1537-1549.
doi: 10.15252/embj.201593489
|
37 |
FERNÁNDEZ-CHACÓNR, WÖLFELM, NISHIMUNEH, et al.The synaptic vesicle protein CSPα prevents presynaptic degeneration[J]Neuron, 2004, 42( 2): 237-251.
doi: 10.1016/s0896-6273(04)00190-4
|
38 |
WELTONT, CARDOSOF, CARRJ A, et al.Essential tremor[J]Nat Rev Dis Primers, 2021, 7( 1): 83.
doi: 10.1038/s41572-021-00314-w
|
39 |
VILARIÑO-GÜELLC, RAJPUTA, MILNERWOODA J, et al.DNAJC13 mutations in Parkinson disease[J]Hum Mol Genet, 2014, 23( 7): 1794-1801.
doi: 10.1093/hmg/ddt570
|
40 |
RAJPUTA, ROSSJ P, BERNALESC Q, et al.VPS35 and DNAJC13 disease-causing variants in essential tremor[J]Eur J Hum Genet, 2015, 23( 6): 887-888.
doi: 10.1038/ejhg.2014.164
|
41 |
ROSSJ P, DUPREN, DAUVILLIERSY, et al.Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson’s disease[J]Neurobiol Aging, 2016, 212.e13-212.e17.
doi: 10.1016/j.neurobiolaging.2016.04.023
|
1 |
ZHOUJ, JANGILIP, SONS, et al.Fluorescent diagnostic probes in neurodegenerative diseases[J/OL]Adv Mater, 2020, 32( 51): e2001945.
doi: 10.1002/adma.202001945
|
2 |
BROWND G, WOBSTH J. Opportunities and challenges in phenotypic screening for neurodegenerative disease research[J]J Med Chem, 2020, 63( 5): 1823-1840.
doi: 10.1021/acs.jmedchem.9b00797
|
3 |
PEMBERTONS, MADIONAK, PIERIL, et al.HSC70 protein interaction with soluble and fibrillar α-synuclein[J]J Biol Chem, 2011, 286( 40): 34690-34699.
doi: 10.1074/jbc.M111.261321
|
4 |
EVERTB O, NALAVADER, JUNGVERDORBENJ, et al.Upregulation of miR-370 and miR-543 is associated with reduced expression of heat shock protein 40 in spinocerebellar ataxia type 3[J/OL]PLoS One, 2018, 13( 8): e0201794.
doi: 10.1371/journal.pone.0201794
|
5 |
HASEGAWAT, YOSHIDAS, SUGENON, et al.DNAJ/HSP40 family and parkinson’s disease[J]Front Neurosci, 2017, 743.
doi: 10.3389/fnins.2017.00743
|
6 |
YANP, RENJ, ZHANGW, et al.Protein quality control of cell stemness[J]Cell Regen, 2020, 9( 1): 22.
doi: 10.1186/s13619-020-00064-2
|
7 |
QIUX B, SHAOY M, MIAOS, et al.The diversity of the DNAJ/HSP40 family, the crucial partners for HSP70 chaperones[J]Cell Mol Life Sci, 2006, 63( 22): 2560-2570.
doi: 10.1007/s00018-006-6192-6
|
8 |
DIANEA, ABUNADAH, KHATTABN, et al.Role of the DNAJ/HSP40 family in the pathogenesis of insulin resistance and type 2 diabetes[J]Ageing Res Rev, 2021, 101313.
doi: 10.1016/j.arr.2021.101313
|
9 |
MOSSERD D, MORIMOTOR I. Molecular chaperones and the stress of oncogenesis[J]Oncogene, 2004, 23( 16): 2907-2918.
doi: 10.1038/sj.onc.1207529
|
10 |
ZAROUCHLIOTIC, PARFITTD A, LIW, et al.DNAJ proteins in neurodegeneration: essential and protective factors[J]Phil Trans R Soc Lond B Boil Sci, 2018, 373( 1738): 20160534.
doi: 10.1098/rstb.2016.0534
|
11 |
HARTLF U. Molecular chaperones in cellular protein folding[J]Nature, 1996, 381( 6583): 571-580.
doi: 10.1038/381571a0
|
12 |
BATESG P, DORSEYR, GUSELLAJ F, et al.Huntington disease[J]Nat Rev Dis Primers, 2015, 1( 1): 15005.
doi: 10.1038/nrdp.2015.5
|
13 |
RODRÍGUEZ-GONZÁLEZC, LINS, ARKANS, et al.Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation[J]Sci Rep, 2020, 10( 1): 8130.
doi: 10.1038/s41598-020-65046-5
|
14 |
LIX, LIUH, FISCHHABERP L, et al.Toward therapeutic targets for SCA3: insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance[J]Prog Neurobiol, 2015, 34-58.
doi: 10.1016/j.pneurobio.2015.06.004
|
15 |
CHAIY, KOPPENHAFERS L, BONININ M, et al.Analysis of the role of heat shock protein (HSP) molecular chaperones in polyglutamine disease[J]J Neurosci, 1999, 19( 23): 10338-10347.
doi: 10.1523/JNEUROSCI.19-23-10338.1999
|
16 |
GESSB, AUER-GRUMBACHM, SCHIRMACHERA, et al.HSJ1-related hereditary neuropathies: novel mutations and extended clinical spectrum[J]Neurology, 2014, 83( 19): 1726-1732.
doi: 10.1212/WNL.0000000000000966
|
17 |
SAVERIP, MAGRIS, MADERNAE, et al.DNAJB2 ‐related Charcot‐Marie‐Tooth disease type 2: pathomechanism insights and phenotypic spectrum widening[J]Euro J Neurol, 2022, 29( 7): 2056-2065.
doi: 10.1111/ene.15326
|
18 |
LABBADIAJ, NOVOSELOVS S, BETTJ S, et al.Suppression of protein aggregation by chaperone modification of high molecular weight complexes[J]Brain, 2012, 135( 4): 1180-1196.
doi: 10.1093/brain/aws022
|
19 |
WESTHOFFB, CHAPPLEJ P, VAN DER SPUYJ, et al.HSJ1 is a neuronal shuttling factor for the sorting of chaperone clients to the proteasome[J]Curr Biol, 2005, 15( 11): 1058-1064.
doi: 10.1016/j.cub.2005.04.058
|
20 |
SCHNAIDERT, SŐTIC, CHEETHAMM E, et al.Interaction of the human DNAJ homologue, HSJ1b with the 90 kDa heat shock protein, Hsp90[J]Life Sci, 2000, 67( 12): 1455-1465.
doi: 10.1016/S0024-3205(00)00735-9
|
21 |
OTTAVIANID, MARINO, ARRIGONIG, et al.Protein kinase CK2 modulates HSJ1 function through phosphorylation of the UIM2 domain[J]Hum Mol Genet, 2017, 26( 3): 611-623.
doi: 10.1093/hmg/ddw420
|
22 |
GROENE J N, TALBOTK, GILLINGWATERT H. Advances in therapy for spinal muscular atrophy: promises and challenges[J]Nat Rev Neurol, 2018, 14( 4): 214-224.
doi: 10.1038/nrneurol.2018.4
|
23 |
SANCHEZE, DARVISHH, MESIASR, et al.Identification of a large DNAJB2 deletion in a family with spinal muscular atrophy and Parkinsonism[J]Hum Mutat, 2016, 37( 11): 1180-1189.
doi: 10.1002/humu.23055
|
24 |
CHAPPLEJ P, CHEETHAMM E. The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation[J]J Biol Chem, 2003, 278( 21): 19087-19094.
doi: 10.1074/jbc.M212349200
|
25 |
BLUMENS C, ASTORDS, ROBINV, et al.A rare recessive distal hereditary motor neuropathy with HSJ1 chaperone mutation[J]Ann Neurol, 2012, 71( 4): 509-519.
doi: 10.1002/ana.22684
|
26 |
LIUM, XUY, HONGD, et al.DNAJB2 c.184C>T mutation associated with distal hereditary motor neuropathy with rimmed vacuolar myopathy[J]Clin Neuropathol, 2022, 41( 9): 226-232.
doi: 10.5414/NP301466
|
27 |
GOEDERTM, COMPSTONA. Parkinson’s disease —— the story of an eponym[J]Nat Rev Neurol, 2018, 14( 1): 57-62.
doi: 10.1038/nrneurol.2017.165
|
28 |
HUSSEINR M, HASHEMR M, RASHEDL A. Evaluation of the amyloid beta-GFP fusion protein as a model of amyloid beta peptides-mediated aggregation: a study of DNAJB6 chaperone[J]Front Mol Neurosci, 2015, 40.
doi: 10.3389/fnmol.2015.00040
|
29 |
DESHAYESN, ARKANS, HANSENC. The molecular chaperone DNAJB6, but not DNAJB1, suppresses the seeded aggregation of alpha-synuclein in cells[J]Int J Mol Sci, 2019, 20( 18): 4495.
doi: 10.3390/ijms20184495
|
30 |
ARKANS, LJUNGBERGM, KIRIKD, et al.DNAJB6 suppresses alpha-synuclein induced pathology in an animal model of Parkinson’s disease[J]Neurobiol Dis, 2021, 105477.
doi: 10.1016/j.nbd.2021.105477
|
31 |
THOMPSONR, STRAUBV. Limb-girdle muscular dystrophies —— international collaborations for translational research[J]Nat Rev Neurol, 2016, 12( 5): 294-309.
doi: 10.1038/nrneurol.2016.35
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|